16 Sep 2010 | MODE Diagnostics gets a Boost
MODE Diagnostics, a University of Glasgow spin-out company, has secured £600,000 funding to develop novel diagnostic screening products for use in the home. The money, supplied by the IP Group of London and Scottish Enterprise’s Co-investment Fund, will aid the development of products which will allow consumers to check themselves for a range of diseases including Bowel Cancer. MODE’s products are based upon a company invention that enables highly selective and sensitive detection of defined markers of disease using novel electrochemical sensors. This patented invention provides quantitative results in under five minutes and is suitable for use in low-cost, handheld devices similar in size to today’s iPods.
MODE Diagnostics, formerly Wireless bioDevices, was spun out of Glasgow University in 2007 by daVinci Ventures in cooperation with the founding academics, the University commercialisation team and IP Group.
For more information click here
« back
MODE Diagnostics, a University of Glasgow spin-out company, has secured £600,000 funding to develop novel diagnostic screening products for use in the home. The money, supplied by the IP Group of London and Scottish Enterprise’s Co-investment Fund, will aid the development of products which will allow consumers to check themselves for a range of diseases including Bowel Cancer. MODE’s products are based upon a company invention that enables highly selective and sensitive detection of defined markers of disease using novel electrochemical sensors. This patented invention provides quantitative results in under five minutes and is suitable for use in low-cost, handheld devices similar in size to today’s iPods.
MODE Diagnostics, formerly Wireless bioDevices, was spun out of Glasgow University in 2007 by daVinci Ventures in cooperation with the founding academics, the University commercialisation team and IP Group.
For more information click here
« back
